Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...

The CDC says the risk of bird flu to the general public is low, but public health experts say they are worried the virus could mutate and become more transmissible.

Moderna stock jumped early Tuesday after the first bird-flu death was reported in the U.S.Shares were up 3.3% to $43.98 in ...

Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first ...

The bird flu, also known as avian influenza and H5N1, was implicated in the first human death from the infectious disease on ...

Officials say the risk is generally low but urged Americans to take precautions while health experts closely monitor the ...

The first known death from a bird flu virus in the US has sparked fears about another pandemic, yet the overall risk to the general public still remains low ...

The strain is spreading among US dairy cows, and has infected dozens of people, mainly US farm workers. Read more at ...

The first human death from bird flu in the United States has intensified calls for the government to ramp up efforts to stave ...

The U.S. has developed a bird flu vaccine that can be prepared when needed. It’s not currently available because health ...

A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.

Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could ...